We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+0.98%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$14.4B
AUM Growth
-$202M
Cap. Flow
+$20.7M
Cap. Flow %
0.14%
Top 10 Hldgs %
9.45%
Holding
521
New
56
Increased
102
Reduced
204
Closed
55

Sector Composition

Rank Sector Weight
1 Technology 20.11%
2 Industrials 16.58%
3 Healthcare 16.32%
4 Consumer Discretionary 13.18%
5 Financials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTE icon
226
TotalEnergies
TTE
$196B
$22.8M 0.16%
438,881
+76,457
+21% +$3.96M
KURA icon
227
Kura Oncology
KURA
$791M
$22.8M 0.16%
1,502,217
VOYA icon
228
Voya Financial
VOYA
$9.01B
$22.7M 0.16%
417,487
-438,575
-51% -$23.4M
PEP icon
229
PepsiCo
PEP
$191B
$22.5M 0.16%
163,911
LGND icon
230
Ligand Pharmaceuticals
LGND
$5.84B
$22.3M 0.16%
359,748
ALGN icon
231
Align Technology
ALGN
$12.1B
$21.8M 0.15%
120,387
-89,621
-43% -$18.6M
WMGI
232
DELISTED
Wright Medical Group Inc
WMGI
$21.6M 0.15%
1,046,373
SYY icon
233
Sysco
SYY
$40.8B
$21.4M 0.15%
269,493
CPRT icon
234
Copart
CPRT
$27B
$21.1M 0.15%
1,050,100
+503,400
+92% +$9.77M
EYE icon
235
National Vision
EYE
$1.76B
$20.9M 0.15%
868,076
-340,145
-28% -$9.91M
ALLY icon
236
Ally Financial
ALLY
$13.1B
$20.9M 0.15%
+629,650
New +$20.4M
CFG icon
237
Citizens Financial Group
CFG
$30.3B
$20.9M 0.15%
589,825
-447,875
-43% -$15.6M
SRE icon
238
Sempra
SRE
$58.4B
$20.8M 0.15%
282,034
PFE icon
239
Pfizer
PFE
$143B
$20.8M 0.14%
609,285
+214,384
+54% +$7.8M
ALB icon
240
Albemarle
ALB
$13.8B
$20.7M 0.14%
298,218
-125,475
-30% -$8.55M
GCO icon
241
Genesco
GCO
$423M
$20.7M 0.14%
516,090
BLUE
242
DELISTED
bluebird bio
BLUE
$20.6M 0.14%
17,293
LFUS icon
243
Littelfuse
LFUS
$11.3B
$20.5M 0.14%
115,457
-65,000
-36% -$11M
PLD icon
244
Prologis
PLD
$135B
$20.3M 0.14%
238,556
EVR icon
245
Evercore
EVR
$12.4B
$20.3M 0.14%
252,900
-85,775
-25% -$7.11M
ABMD
246
DELISTED
Abiomed Inc
ABMD
$20.2M 0.14%
113,675
-194,817
-63% -$42.1M
MSI icon
247
Motorola Solutions
MSI
$72.1B
$20.1M 0.14%
+118,225
New +$20.3M
EVH icon
248
Evolent Health
EVH
$340M
$20.1M 0.14%
2,801,065
+1,167,612
+71% +$8.38M
EBAY icon
249
eBay
EBAY
$50.3B
$20.1M 0.14%
514,725
-242,575
-32% -$9.73M
PGNX
250
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$20M 0.14%
3,948,024

Similar funds

Carillon Tower Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, Carillon Tower Advisers held 521 positions worth $14.4B, down 1.4% from $14.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Carillon Tower Advisers's Q3 2019 filing shows 56 new, 102 increased, 204 reduced and 55 closed positions. Its largest new stake was Fidelity National Information Services: 608,629 shares worth $80.8M. The largest sale was Edwards Lifesciences, an estimated $88.1M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.

  • Carillon Tower Advisers's largest Q3 2019 buy was Fidelity National Information Services: 608,629 shares worth $80.8M.
  • Carillon Tower Advisers added most to Teleflex in Q3 2019, an estimated $60.5M increase.
  • Carillon Tower Advisers's biggest Q3 2019 reduction was Edwards Lifesciences, cutting an estimated $88.1M.
  • Carillon Tower Advisers fully exited Worldpay, Inc. in Q3 2019, selling an estimated $69.2M.
  • Carillon Tower Advisers's ten largest holdings make up 9.5% of its $14.4B portfolio in Q3 2019.
  • Carillon Tower Advisers opened 56 new positions and closed 55 in Q3 2019.
  • Carillon Tower Advisers's portfolio value fell 1.4% quarter-over-quarter to $14.4B.

Based on Carillon Tower Advisers's 13F filing for Q3 2019, filed 5 Nov 2019.